Fate Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FATE and other ETFs, options, and stocks.

About FATE

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates. 

CEO
Bahram Valamehr
CEOBahram Valamehr
Employees
161
Employees161
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2007
Founded2007
Employees
161
Employees161

FATE Key Statistics

Market cap
348.51M
Market cap348.51M
Price-Earnings ratio
-2.74
Price-Earnings ratio-2.74
Dividend yield
Dividend yield
Average volume
6.70M
Average volume6.70M
High today
$3.12
High today$3.12
Low today
$2.84
Low today$2.84
Open price
$2.93
Open price$2.93
Volume
3.39M
Volume3.39M
52 Week high
$3.21
52 Week high$3.21
52 Week low
$0.91
52 Week low$0.91

Stock Snapshot

The current Fate Therapeutics(FATE) stock price is $3.05, with a market capitalization of 348.51M. The stock trades at a price-to-earnings (P/E) ratio of -2.74.

On 2026-07-06, Fate Therapeutics(FATE) stock moved within a range of $2.84 to $3.12. With shares now at $3.05, the stock is trading +7.3% above its intraday low and -2.4% below the session's peak.

Trading activity shows a volume of 3.39M, compared to an average daily volume of 6.7M.

The stock's 52-week range extends from a low of $0.91 to a high of $3.21.

The stock's 52-week range extends from a low of $0.91 to a high of $3.21.

FATE News

Simply Wall St 13h
Fate Therapeutics Insiders Benefit From Selling Stock At US$1.54

While Fate Therapeutics, Inc. ( ) shareholders have had a good week with the stock up 21%, insiders can't say the same having sold stock over the past year. The...

Fate Therapeutics Insiders Benefit From Selling Stock At US$1.54

Analyst ratings

50%

of 12 ratings
Buy
50%
Hold
50%
Sell
0%

People also own

Based on the portfolios of people who own FATE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.